New Times,
New Thinking.

  1. Business
  2. Economics
30 November 2012

Neil O’Brien appointed special adviser to Osborne

Policy Exchange director will focus on developing the Conservatives' next manifesto.

By George Eaton

George Osborne has just completed his second big signing of the week. After naming Mark Carney as governor of the Bank of England on Monday, he’s secured the services of Policy Exchange director Neil O’Brien as a special adviser. O’Brien, who has been director of the cente-right think-tank since 2008, will focus on the development of the Conservatives’ next general election manifesto.

It’s a smart move by Osborne; O’Brien, a New Statesman contributor, is one of the most innovative conservative thinkers of his generation and a moderniser who understands what the Tories need to do if they’re to stand a chance of winning in 2015. In a piece for the NS last month (“The challenge for the Tories is to find their own version of Blairism”), he wrote:

At the next election, Tory candidates need a clearer offering for those who work hard on low incomes; something to say to the fifth of households that live in social housing; and an agenda that makes sense to people in areas of high unemployment and to the millions who work in public services.

As he showed in another piece for the NS, on the meaning of “Milibandism“, he also understands the threat posed by Labour.

Policy Exchange deputy director David Skelton, another NS contributor, will serve as acting director while the think-tank looks for a replacement for O’Brien. Congratulations to both.

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

Content from our partners
Unlocking investment in UK life sciences through manufacturing
Data defines a new era for fundraising
A prescription for success: improving the UK's access to new medicines